In vivo is on twitter

@invivo_CHUV
Partnership with Republic of Innovation
Follow us

We prefer #Friday. Why? Because of the #optimism bias! Discover why our #brain sees the glass half full. t.co/syV6sJXcHs

RT @Confprof: Congress Chair of ESPACOMP on national radio interview t.co/xlgR3sYMRF … @CHUVLausanne @invivo_CHUV @MyLausanne @MySwi…

Mymetics announces new collaboration to advance the development of an innovative Malaria vaccine candidate - t.co/3yBujQIGqR

Google wants to store your genome! - t.co/sAmA8aQKUF

Contrôler les gènes par la pensée! - t.co/yaTpoRO271

Exposition LAB/LIFE: Rencontres avec les chercheurs - t.co/mGGEpWMhZq

Philae a pu «renifler» des molécules organiques - t.co/f5d0R9GXRp

Givaudan ouvre un centre à Dubai - t.co/uIIwmazBB7

Pilule amère, Alexion quitte Lausanne - t.co/mlCBaAtyuG

Mens Sana / Décryptage

The Science of Optimism

Cursus / Portrait

“Innovation is our greatest value"

Corpore Sano / Décryptage

The challenges of old age

Corpore Sano / Prospection

DNA does not tell everything

Mens Sana / Interview

“I’m con-cerned about the price”

Corpore Sano / Décryptage

Protons versus cancer

Cursus / Tandem

The Swiss Cancer Center, Lausanne

Focus / Editorial

A weight gene

Corpore Sano / Prospection

Botox: new relief for migraine sufferers

Focus / Editorial

Pleasure comes slow-cooked

In Situ / Et ailleurs

Hand-held doctor

In Situ / Health Valley

Developing the ecosystem… grounding our companies

Mens Sana / Innovation

Remote-controlled medicine

Focus / Editorial

Staying fit through healthy eating

Our favourite Twitter feeds